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Cervical carcinomaAbstract Aim: To determine role of trans-vaginal sono-elastography in differentiation between
normal and diseased cervix and whether strain ration can be used for characterization of cervical
carcinoma in postmenopausal women.
Patients and methods: From January 2012 to October 2013, seventy consecutive postmenopausal
women were examined by trans-vaginal elastography. The 70 women included: (1) control group
(30 healthy women) and (2) diseased group (40 patients). Pathological results were used as the gold
standard. Strain ratios were calculated and compared between normal (control) and abnormal (dis-
eased) cervix, also between benign and malignant lesions. The accuracies of SR in differentiating
benign and malignant cervical lesions were assessed with the Student’s t test and receiver operating
characteristic curve (ROC) analysis.
Results: There was statistically difference in mean SR between normal and abnormal cervix and
between malignant and benign cervical lesions (p< 0.0001 and p< 0.0001 respectively). SR of
3.4 resulted in 100% sensitivity, 100% speciﬁcity and 100% accuracy for differentiation between
normal and diseased cervix. SR of 8.7 resulted in 93.8% sensitivity, 100% speciﬁcity and 95% accu-
racy in differentiation between malignant and benign cervical lesions.
Conclusion: TV sono-elastography is a useful technique in differentiation between normal and
abnormal cervix and between malignant and benign cervical lesions.
 2015 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Worldwide, cervical cancer is the second most common malig-
nancy in women (1,2). In Western countries, most of cervicalcancer is usually diagnosed at an early stage of the disease.
The most common clinical staging system is the International
Federation of Gynecology and Obstetrics (FIGO) and it
remains the standard for staging and treatment decision in
patients with cervical cancer (3). It takes into account the
results of the physical examination, histopathology results of
biopsy, colposcopy, endoscopy (cystoscopy or sigmoidoscopy)
and chest radiography. Despite that surgical and modern
1292 M. Shady et al.imaging staging is proved to be better than clinical staging for
identifying the true extent of the disease, none of these meth-
ods have been incorporated into the FIGO staging system
yet. The main reason is that the disease commonly affects
developing countries, basically due to the absence of cervical
cancer screening, as staging methods are not universally
available, standardized, or comparable to those present in
developed countries. Also, there is still a lack of the clinical
value of surgical staging and the consensus about the best
imaging modality (4) (see Figs. 1–5).
Current imaging modalities used for the assessment of uter-
ine cervical cancer include magnetic resonance imaging (MRI),
computed tomography (CT), and ultrasound. In comparison,
CT has a low contrast resolution of soft-tissue, while MRI is
the ideal modality for the evaluation of the cervix. However,
MRI is not usually performed immediately in regard to conve-
nience and the limitations of intra-uterine contraceptive
devices. On the other side, ultrasound is gaining clinical impor-
tance because it is cheaper, less time consuming and could haveFig. 1 Ultrasound images of a female patient, aged 55 years with no
Doppler image (B) and TV elastogram (C) show healthy cervix with nsimilar diagnostic accuracy as MRI (5). Transvaginal ultra-
sonography (TVUS) arranged with a high resolution probe,
may give a clearer image of the uterine cervix and parametrial
tissue (6) (see Tables 1–3).
It is well-known that the malignant tissues are generally
harder than adjacent normal tissues, and this could distinguish
benignly from malignant tissues based on their elasticity (7–
11). Real-time ultrasound elastography is a rising technique,
now readily available on conventional ultrasound systems with
modiﬁed software. The basic principle in ultrasound elastogra-
phy, is non-invasive imaging and estimation of tissue elasticity
by measuring local tissue displacements from returning ultra-
sonic signals before and after application of a compressive
force. Under compression, stiff tissues show less deformation
or strain than soft tissues. Applying the property that
malignant tissues have higher stiffness than benign tissues,
ultrasound elastography has been shown to differentiate
malignant from benign lesions in the prostate, breast,
liver, pancreas, lymph nodes, and gastrointestinal tractrmal cervix (control group). B-mode ultrasound image (A), color
ormal vascularity and SR = 1.51.
Fig. 2 Ultrasound images of a female patient, aged 52 years with multiple uterine and cervical ﬁbroids. B-mode ultrasound image (A)
and TV elastogram (B) show multiple well deﬁned hypoechoic ﬁbroid masses in the cervix with its SR = 6.74.
Benign-malignant differentiation of cervical masses 1293(7,10,12–18). In addition, there are promising results showing
that ultrasound elastography has a high accuracy for predict-
ing malignant thyroid nodules (11,19–27). However, little
effort was done on the detection and diagnosis of cervical can-
cer until now.
2. Aim of study
The aim of this study was to evaluate the role of TV sono-
elastography in differentiation between normal and abnormal
(diseased) cervix and whether the strain ration (SR) can be
used for characterization of cervical carcinoma in post-
menopausal women.3. Patients and methods
3.1. Patients
During the period from January 2012 to October 2013, seventy
consecutive postmenopausal women were enrolled, and their
age ranged from 55 to 70 years with a mean age of 62.5 years.
The 70 patients were divided into 2 groups: ﬁrst, the control
group that included 30 healthy women, and second the dis-
eased group that included 40 patients. Inclusion criterion for
the diseased group was the presence of lesions in the uterine
cervix. Patients with history of radiotherapy and cervical can-
cer patients with vaginal involvement were excluded to avoid
Fig. 3 Ultrasound images of a female patient, aged 67 years with malignant cervical mass (conﬁrmed to be invasive cervical squamous
carcinoma by pathological examination). B-mode ultrasound image (A), color Doppler image (B) and TV elastogram (C) show illdeﬁned
mass with increased vascularity and its SR = 13.8.
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the Human Study Committee were taken from all participated
patients.
3.2. Methods
All the enrolled patients accepted TV-sono-elastography
scanning one week before the conization treatment or surgery.
Clinical staging and treatment plan of cervical cancers were
deﬁned according to the staging system revised by the
International Federation of Gynecology and Obstetrics
(FIGO) (28,29) in 2009.
3.2.1. Acquisition of the elastograms
Real-time TV sono-elastography was carried out by using
aplio XG system (Toshiba Medical System, Tokyo, Japan)
with a 7.0-MH endo-vaginal probe. All the examinations wereperformed by 2 independent radiologists (M.S. and M.A.).
Both have experiences of 25 and 15 years respectively in female
ultrasonic scanning. They were blinded to the colposcopy and
physical examination results.
Patients were asked to empty bladder and lie in the litho-
tomy position. The TV ultrasound probe was put into the
vagina about 1 cm away from the cervix with a disposable con-
dom which was used to prevent crossinfection. The site, shape,
size, and echogenicity of the cervical lesions were recorded.
Power and Color Doppler were used to assess the blood supply
of the lesions. The highest sensitivity for detection of color
Doppler signals was used, allowing detection of small blood
ﬂow velocities. Then, the system was turned into elastography
mode to record the stiffness of the cervix and the lesions. Sup-
port of the anterior pelvic wall by the left hand and manual
compression on the cervix by the right hand were done. The
parameters used were as follows: frame rate M; density 2;
dynamic range 4; Persistence 6; smoothing 2; frame rejection
Fig. 4 Ultrasound images of a female patient, aged 63 years with malignant cervical mass (conﬁrmed to be cervical adeno-carcinoma by
pathological examination). B-mode ultrasound image (A), color Doppler image (B) and TV elastogram (C) show illdeﬁned hypoechoic
mass with increased vascularity and its SR = 16.38.
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represented by color overlaid. The color scale ranges from blue
to red to show the relative hardness or softness of tissue in the
region of interest (ROI) as: tissue with average strain was colored
in green, hard tissue was dark blue, moderately hard tissue in
light blue, moderately soft tissue areas in yellow, and soft tissue
areas in red. On average, 4 (range 3–6) static images and 3 (range
2–5) clips for each lesion were obtained for further assessment.
Strain ratio was obtained by measuring and dividing the
mean strain of the lesion by the mean strain from the parame-
trial tissue, if the lesion was in the anterior cervical wall, the
anterior pericervical fat was taken as the reference tissue and
if the lesion was in the posterior cervical wall, the posterior
pericervical fat was chosen as the reference. So, sufﬁcientparametrial tissue was essential. The reference tissue was difﬁ-
cult to choose if the lesions inﬁltrated both sides of the pelvic
wall and the value of strain ratio would be questionable. How-
ever, we think that un-inﬁltrated uterine myometrium could be
used as a reference.3.2.2. Evaluation of the elastograms
Strain ratio was used to evaluate the hardness of the cervical
tissue half-quantitatively. All the lesions were assessed by the
2 independent radiologists at least 3 times, based on different
static images and the average strain value was recorded as their
ﬁnal results. Both of the observers were blind to the physical
and pathological results.
Fig. 5 Ultrasound images of a female patient, aged 69 years with recurrent malignant cervical mass (conﬁrmed to be cervical squamous
carcinoma by pathological examination). B-mode ultrasound image (A), color Doppler image (B) and TV elastogram (C) show irregular
mass of mixed echogenicity with increased vascularity and its SR = 16.28.
1296 M. Shady et al.Area colored in dark blue was considered to be involved.
Inﬁltration depths of cervical cancers were measured on the
sagittal view.
3.3. Statistical analysis
Statistical analysis was done via Statistical package for social
Science (SPSS) version 17 program on windows XP. Qualita-
tive data were represented in the form of number and fre-
quency, while quantitative data were represented in the form
of mean ± standard deviation (mean ± SD). Kolmogorov–
Smirnov test was used to test normality of quantitative data.
Student’s t test, Mann–Whitney U test and Kruskal–Wallis
Test were used to compare groups. Receiver operating charac-
teristic (ROC) curve was computed to determine the cutoffvalue for the malignancy. All tests were considered signiﬁcant
if P value equals or less than 0.05.
4. Results
The 70 patients enrolled in the study were classiﬁed into con-
trol group (n= 30) and patients group (n= 40). The 40
patients had 27 primary cancer cervix, 5 recurrent cancer cer-
vix, and 8 ﬁbroids.
Mean surface area of all lesions in the patients group was
8.35 ± 4.07 cm2. Mean surface areas of the primary cancer
cervix, recurrent cancer cervix and ﬁbroid lesions were
7.68 ± 3.15 cm2, 5.80 ± 2.77 and 12.18 ± 5.27 cm2
respectively.
Table 1 Mean size and SR of normal (control) cervix and
diseased cervix (benign and malignant lesions).
Report
Pathology SR Size
Control Mean 2.4667
N 30
Std. deviation .46634
Minimum 1.70
Maximum 3.40
Range 1.70
Median 2.5000
Cancer cervix Mean 11.5185 7.6852
N 27 27
Std. deviation 1.94443 3.15054
Minimum 6.50 2.00
Maximum 14.30 14.00
Range 7.80 12.00
Median 11.4000 7.5000
Recurrent cancer cervix Mean 10.6000 5.8000
N 5 5
Std. deviation 1.21861 2.77489
Minimum 9.00 3.00
Maximum 12.40 9.00
Range 3.40 6.00
Median 10.5000 6.0000
Fibroid Mean 6.5625 12.1875
N 8 8
Std. deviation .96353 5.27756
Minimum 5.60 4.00
Maximum 8.70 20.00
Range 3.10 16.00
Median 6.3000 13.0000
Total Mean 7.0071 8.3500
N 70 40
Std. deviation 4.42517 4.07022
Minimum 1.70 2.00
Maximum 14.30 20.00
Range 12.60 18.00
Median 6.4500 7.7500
Benign-malignant differentiation of cervical masses 1297Mean SR of the control group was 2.46 ± 0.46. Mean SR
of the diseased group was 10.41 ± 2.59. Mean SRs of the can-
cer cervix, recurrent cancer cervix and ﬁbroid lesions were
11.51, 10.60 and 6.65 respectively.
Comparison of all SRs revealed that mean SR of the dis-
eased group was signiﬁcantly higher than that of the control
group (P< 0.0001). Also, mean SR of the malignant lesions
(primary and recurrent cancer cervix) was signiﬁcantly higher
than that of the benign lesions (ﬁbroid) (P< 0.0001).
Twenty-four lesions of the 27 primary cancer cervix lesions
had high vascularity at power Doppler imaging, 4 lesions of
the 5 recurrent cancer cervix lesions had high vascularity and
none of the 8 ﬁbroids showed central vascularity with only
peripheral vascularity at power Doppler imaging.
Using the SR of 3.4 as a cutoff value resulted in AUC± SE
of 1.00 ± 0.00, 95% CI of 0.949–1.00, 100% sensitivity, 100%
speciﬁcity, 100% accuracy, 100% PPV and 100% NPV for dif-
ferentiation between control and diseased group.
Using the SR of 8.7 as a cutoff value resulted in AUC± SE
of 0.98 ± 0.017, 95% CI of 0.877–1.00, 93.8% sensitivity,100% speciﬁcity, 95% accuracy, 100% PPV and 80% NPV
in differentiation between malignant and benign lesions.
5. Discussion
Real-time sono-elastography is a new emerging method to
describe the mechanical properties of tissue. It is similar to
color Doppler ultrasonography in that a region of interest is
deﬁned. The relative stiffness of the tissues within this area is
described by colors superimposing on the B-mode image.
Real-time elastography can be performed with linear transduc-
ers for trans-cutaneous use, rigid endo-cavitary probes and
with ﬂexible echo-endoscopes. The probes can be used to com-
press the tissue. The elasticity modulus is calculated from the
resulting deformation of the tissue (30).
Several studies have proved that real-time elastography is
feasible and improves the diagnostic accuracy for tumors of
the breast, the prostate and the thyroid gland. Endosono-
graphic elastography has been used in the examination of
lymph nodes and the pancreas (30). However, to the best of
our knowledge, only few articles have assessed its application
in diagnosis and evaluation of the cervical lesions (6,10,31).
Thomas et al. (10), investigated tissue elasticity of normal
and abnormal cervix and concluded that computer-assisted
and subjective evaluation of cervical elastography allows dif-
ferentiation of malignancy from normal ﬁndings and cervical
tissue is of medium hardness and does not change with age.
In the current study, strain ratio was useful in differentiation
between normal cervix (control group) and pathological cervix
(diseased group) and using the cutoff value of 3.4 resulted in
sensitivity, speciﬁcity and accuracy of 100% for differentiation
between normal and pathological cervix.
Using the strain ratio of 8.7 as a cutoff value resulted in
93.8% sensitivity, 100% speciﬁcity, 95% accuracy, 100%
PPV and 80% NPV for differentiation between malignant (pri-
mary and recurrent cancer cervix) and benign (ﬁbroid) lesions.
In the study of Sun et al. (6), when SR of 4.53 was used as a
cut-off point, sensitivity and speciﬁcity of elastography were
78.8% and 89.7% respectively in differentiating malignant
from benign cervical lesions. They concluded that elastography
should be used combined with conventional B-mode ultra-
sound to provide extra information and help conﬁrming the
diagnoses.
There was no signiﬁcant difference between strain ratios of
primary cervical carcinoma and recurrent cervical carcinoma.
5.1. Limitation
As we said before, un-inﬁltrated uterus could be used as a
reference when the lesions inﬁltrated both sides of the pelvic
wall and we tried that on small number of cases, promising
results were obtained and further investigation in that point
is needed.
Fibroid was selected as a representation of benign cervical
lesions; however, other benign lesions such as erosions, polyps
and inﬂammation were studied by Sun et al. (6), and showed
signiﬁcant differentiation between these benign lesions and cer-
vical carcinoma. Also, in our study, four cases of cervicitis
were studied which gave similar results, but excluded because
of its small number.
Table 2 Mean SR cutoff value for the differentiation between normal (control) and diseased cervix.
Diseased vs control
Cutoﬀ AUC± SE 95% CI Sensitivity (95% CI) Speciﬁcity (95% CI) Accuracy (95% CI) PPV (95% CI) NPV (95% CI)
SR> 3.4 1.00 ± 0.00 0.949–
1.00
100% (91.2–100%) 100 (88.4–100) 100 (92.4–100) 100 (91.2–100%) 100 (88.4–100)
Table 3 Mean SR cutoff value for the differentiation between malignant and benign cervical lesion.
Malignant vs ﬁbroid
Cutoﬀ AUC± SE 95% CI Sensitivity (95% CI) Speciﬁcity (95% CI) Accuracy (95% CI) PPV (95% CI) NPV (95% CI)
SR> 8.7 0.98 ± 0.017 0.877–
1.00
93.8% (79.2–99.2%) 100 (63.1–100) 95 (81.6–95) 100 (91.1–100%) 80 (53.3–80)
1298 M. Shady et al.We concentrated on feasibility of TV sono-elastography in
characterization of cervical carcinoma and we did not compare
its results with those of B-mode ultrasound. This point needs
further investigation in the future.
Also, this study included small number of cases with big
size masses, and future studies with large number of cases
and small sized masses are recommended.6. Conclusion
TV sono-elastography is a useful technique in characterization
of cervical pathology and differentiation between normal and
abnormal cervix and between benign and malignant cervical
lesions.
Benign-malignant differentiation of cervical masses 1299We advice the use of TV sono-elastography as an addi-
tional tool to other used screening modalities. Large scale
research is needed to assess its use as an alternative to biopsy
if SR > 3.4.
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